176 related articles for article (PubMed ID: 31052317)
1. The Preparation, Determination of a Flexible Complex Liposome Co-Loaded with Cabazitaxel and β-Elemene, and Animal Pharmacodynamics on Paclitaxel-Resistant Lung Adenocarcinoma.
Zeng YY; Zeng YJ; Zhang NN; Li CX; Xie T; Zeng ZW
Molecules; 2019 Apr; 24(9):. PubMed ID: 31052317
[TBL] [Abstract][Full Text] [Related]
2. Preparation, characterization, pharmacokinetics and anticancer effects of PEGylated β-elemene liposomes.
Zhai B; Wu Q; Wang W; Zhang M; Han X; Li Q; Chen P; Chen X; Huang X; Li G; Zhang Q; Zhang R; Xiang Y; Liu S; Duan T; Lou J; Xie T; Sui X
Cancer Biol Med; 2020 Feb; 17(1):60-75. PubMed ID: 32296587
[No Abstract] [Full Text] [Related]
3. In vitro combination characterization of the new anticancer plant drug beta-elemene with taxanes against human lung carcinoma.
Zhao J; Li QQ; Zou B; Wang G; Li X; Kim JE; Cuff CF; Huang L; Reed E; Gardner K
Int J Oncol; 2007 Aug; 31(2):241-52. PubMed ID: 17611679
[TBL] [Abstract][Full Text] [Related]
4. Development of β-elemene and Cisplatin Co-Loaded Liposomes for Effective Lung Cancer Therapy and Evaluation in Patient-Derived Tumor Xenografts.
Cao M; Long M; Chen Q; Lu Y; Luo Q; Zhao Y; Lu A; Ge C; Zhu L; Chen Z
Pharm Res; 2019 Jun; 36(8):121. PubMed ID: 31214786
[TBL] [Abstract][Full Text] [Related]
5. Characterization and body distribution of beta-elemene solid lipid nanoparticles (SLN).
Wang Y; Deng Y; Mao S; Jin S; Wang J; Bi D
Drug Dev Ind Pharm; 2005 Sep; 31(8):769-78. PubMed ID: 16221611
[TBL] [Abstract][Full Text] [Related]
6. [The pharmacokinetics of long-circulating beta-elemene liposomes].
Zhang BJ; Li WC; Liu XP
Zhong Yao Cai; 2012 Sep; 35(9):1464-8. PubMed ID: 23451504
[TBL] [Abstract][Full Text] [Related]
7. Drug delivery systems for elemene, its main active ingredient β-elemene, and its derivatives in cancer therapy.
Zhai B; Zeng Y; Zeng Z; Zhang N; Li C; Zeng Y; You Y; Wang S; Chen X; Sui X; Xie T
Int J Nanomedicine; 2018; 13():6279-6296. PubMed ID: 30349250
[TBL] [Abstract][Full Text] [Related]
8. β-Elemene, a compound derived from Rhizoma zedoariae, reverses multidrug resistance mediated by the ABCB1 transporter.
Guo HQ; Zhang GN; Wang YJ; Zhang YK; Sodani K; Talele TT; Ashby CR; Chen ZS
Oncol Rep; 2014 Feb; 31(2):858-66. PubMed ID: 24284783
[TBL] [Abstract][Full Text] [Related]
9. Preclinical antitumor activity of cabazitaxel, a semisynthetic taxane active in taxane-resistant tumors.
Vrignaud P; Sémiond D; Lejeune P; Bouchard H; Calvet L; Combeau C; Riou JF; Commerçon A; Lavelle F; Bissery MC
Clin Cancer Res; 2013 Jun; 19(11):2973-83. PubMed ID: 23589177
[TBL] [Abstract][Full Text] [Related]
10. Active targeting of orthotopic glioma using biomimetic liposomes co-loaded elemene and cabazitaxel modified by transferritin.
Li J; Zeng H; You Y; Wang R; Tan T; Wang W; Yin L; Zeng Z; Zeng Y; Xie T
J Nanobiotechnology; 2021 Sep; 19(1):289. PubMed ID: 34565383
[TBL] [Abstract][Full Text] [Related]
11. Formulation optimization of an ephrin A2 targeted immunoliposome encapsulating reversibly modified taxane prodrugs.
Huang ZR; Tipparaju SK; Kirpotin DB; Pien C; Kornaga T; Noble CO; Koshkaryev A; Tran J; Kamoun WS; Drummond DC
J Control Release; 2019 Sep; 310():47-57. PubMed ID: 31400383
[TBL] [Abstract][Full Text] [Related]
12. Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response.
Jiang L; Li L; He X; Yi Q; He B; Cao J; Pan W; Gu Z
Biomaterials; 2015 Jun; 52():126-39. PubMed ID: 25818419
[TBL] [Abstract][Full Text] [Related]
13. The mechanism of m
Liu S; Li Q; Li G; Zhang Q; Zhuo L; Han X; Zhang M; Chen X; Pan T; Yan L; Jin T; Wang J; Lv Q; Sui X; Xie T
Cell Death Dis; 2020 Nov; 11(11):969. PubMed ID: 33177491
[TBL] [Abstract][Full Text] [Related]
14. PEGylated lipid microspheres loaded with cabazitaxel for intravenous administration: stability, bioavailability, antitumor efficacy, and toxicity.
Liu Y; Xie B; Li L; Zhang X; Zhang Y; He H; Yin T; Tang X; Cai C; Gou J
Drug Deliv Transl Res; 2018 Oct; 8(5):1365-1379. PubMed ID: 30019282
[TBL] [Abstract][Full Text] [Related]
15. β-Elemene against human lung cancer via up-regulation of P53 protein expression to promote the release of exosome.
Li J; JunYu ; Liu A; Wang Y
Lung Cancer; 2014 Nov; 86(2):144-50. PubMed ID: 25204604
[TBL] [Abstract][Full Text] [Related]
16. [Synergistic effect of beta-elemene injection combined paclitaxel injection on human breast cancer MB-468 cells: an in vitro study].
Cai DY; Gao X; Wu XH; Hong TT
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jul; 33(7):978-82. PubMed ID: 24063225
[TBL] [Abstract][Full Text] [Related]
17. Can taxanes provide benefit in patients with CNS tumors and in pediatric patients with tumors? An update on the preclinical development of cabazitaxel.
Sémiond D; Sidhu SS; Bissery MC; Vrignaud P
Cancer Chemother Pharmacol; 2013 Sep; 72(3):515-28. PubMed ID: 23820961
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel/hydroxypropyl-β-cyclodextrin complex-loaded liposomes for overcoming multidrug resistance in cancer chemotherapy.
Shen Q; Shen Y; Jin F; Du YZ; Ying XY
J Liposome Res; 2020 Mar; 30(1):12-20. PubMed ID: 30741058
[TBL] [Abstract][Full Text] [Related]
19. Arginine, glycine, aspartic acid peptide-modified paclitaxel and curcumin co-loaded liposome for the treatment of lung cancer: in vitro/vivo evaluation.
Jiang K; Shen M; Xu W
Int J Nanomedicine; 2018; 13():2561-2569. PubMed ID: 29731631
[TBL] [Abstract][Full Text] [Related]
20. Preclinical profile of cabazitaxel.
Vrignaud P; Semiond D; Benning V; Beys E; Bouchard H; Gupta S
Drug Des Devel Ther; 2014; 8():1851-67. PubMed ID: 25378905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
